4 |
4
제3항에 있어서, 상기 성장인자는 섬유아세포 성장인자(fibroblast growth factor, FGF), 혈관내피세포 성장인자(vascular endothelial growth factor, VEGF), 상피성장인자 (epidermal growth factor, EGF), 결합조직성장인자(connective tissue growth factor, CTGF), 인슐린유사 성장인자(insulin-like growth factor, IGF), 형질전환 성장 인자(transforming growth factor, TGF), 신경 성장인자(nerve growth factor, NGF), 간세포 성장인자 (hepatocyte growth factor, HGF), 혈소판유래 성장인자 (platelet-derived growth factor, PDGF), 뼈유래 성장인자(bone-derived growth factor, BDGF), 줄기세포 인자(stem cell factor, 백혈병 억제 인자 (Leukemia inhibitory factor, LIF), 뇌유래 신경성장 인자(Brain-derived neurotrophic factor, BDNF), 교질세포 유래 신경성장 인자 (Glial-derived neurotrophic factor, GDNF), 액티빈 A (Activin A), 노긴(Noggin), 골형태형성 단백질 2(bone morphogenetic protein 2, BMP2), 골형태형성단백질 4(bone morphogenetic protein 4, BMP4), 엔지오포이에틴 1(Angiopoietin-1), SHH (sonic hedgehog), Wnt, FLT-3 리간드(FMS-related tyrosine kinase 3 ligand) 및 콜로니 자극 인자(colony stimulation factor, CSF)로 이루어진 군에서 선택된 하나 이상인, 조성물
|